Toronto, Canada
Genetics Adviser, founded in 2022 and headquartered in Canada, is an innovative player in the digital health sector. The company is carving out a niche by delivering a versatile platform that enhances patient engagement and supports clinicians in the realm of genomic medicine.
The platform is designed to facilitate ease of use with features like pre-test education, digital consent, and long-term patient management. This makes it an invaluable tool for medical professionals aiming to streamline workflows and scale precision genomic medicine delivery.
With its presence in the Health Care, Internet, and Mobile industries, the company aligns with key healthcare trends and positions itself as a leader in digital health solutions.
Recently, Genetics Adviser secured a Seed Round investment led by Archangel Network of Funds and Toronto Innovation Acceleration Partners on 01 January 2023. This injection of capital underscores robust investor confidence and sets the stage for future growth and development.
